› Forums › General Melanoma Community › Just In..Local Delivery of lnterleukin-12 using T cells Targeting VEGFR shrinks Melanoma Tumors.
- This topic is empty.
- Post
-
- March 16, 2012 at 5:57 pm
"There are not many times that I am truly speechless but this is close to being one of them. We saw Dr. Stewart and Dr. Yang yesterday and if you noticed, the sun got just a little brighter about 2:30 yesterday afternoon. That is because they told us that all of Patty's tumors have shrunk 26%!!! The first thing Dr. Yang did when he walked in the door was to give Pat a hug. He and Dr. Rosenberg both are extremely excited about this. Apparently they were discussing Patty's progress on rounds up on the floor in the morning before we got to the hospital.
"There are not many times that I am truly speechless but this is close to being one of them. We saw Dr. Stewart and Dr. Yang yesterday and if you noticed, the sun got just a little brighter about 2:30 yesterday afternoon. That is because they told us that all of Patty's tumors have shrunk 26%!!! The first thing Dr. Yang did when he walked in the door was to give Pat a hug. He and Dr. Rosenberg both are extremely excited about this. Apparently they were discussing Patty's progress on rounds up on the floor in the morning before we got to the hospital. We stopped up to see the gang on 3NW and all of the nurses were excited to see her as well. We’ll be going back in another month for more scans, after all it is research and she is a pioneer! Don't know what else to say, just thank you everyone for all of the prayers, cards and words of encouragement. And thank you Lord for watching over Patty. Have a wonderful day!! "
The shrinkage is so exciting. This means that Dr. Roesenberg's theory of secreting IL-12 from engineered T-cells is a plausable therapy.
Redirecting the Melanoma Tumor’s Microenvironment in Favor of the Activation of T-cells
Best Regards,
Jimmy B
- You must be logged in to reply to this topic.